CMS Open Payments · Program Year 2024
Agilent Technologies, Inc.
Agilent Technologies, Inc. reported $1,213,515.70 across General Payments, Research, and Ownership to 61 physicians and teaching hospitals across 61 transactions.
- $1.2M Above-median payer
- All-tracks total
- 61 Below-median volume
- Transactions
- 61 Below-median reach
- Recipients
- −$32.6K
- General Payments vs PY2023
Agilent Technologies, Inc. reported $1,213,515.70 across all CMS Open Payments tracks (General + Research + Ownership) to 61 physicians and teaching hospitals in Program Year 2024 - ranking #577 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,213,515.70, averaging $19.9K per recipient.
How Agilent Technologies, Inc.'s $1.2M all-tracks total breaks down
Agilent Technologies, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
30/100
Total payments
F
21/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer agilent-technologies-inc Agilent Technologies, Inc.
$1.2M · #577/1,925 · 0.0% industry · PY2024
- TOT $1.2M
- RANK #577
- SHARE 0.0%
- TXN 61
- RCP 61
- CAT 6
- GEN $1.2M
- ΔGEN −$32.6K
- TOP1 28.7%
- PY 2024
Volume peers
Nearest volume peer: FX Shoulder Solutions, Inc ($1.2M)
Agilent Technologies, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Agilent Technologies, Inc.'s CMS-reported General Payments decreased by $32.6K (−2.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AGILENT TECHNOLOGIES, INC.PY2023: AGILENT TECHNOLOGIES, INC.PY2024: Agilent Technologies, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,246,087.71
- PY2024
- $1,213,515.70
What the Data Shows for Agilent Technologies, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Agilent Technologies, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
13 transactions worth $523.8K make "Royalty or License" the top general-payment category in the 6-category breakdown below, 43.2% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Agilent Technologies, Inc. made 6 types of general payments. "Royalty or License" is the largest category at $523.8K, 43.2% of General Payments.
Agilent Technologies, Inc. reports 6 general-payment categories - the top three are Royalty or License (43.2%), Grant (36.4%), and Long-Term Medical Supply or Device Loan (14.2%). The remaining 3 categories make up 6.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Agilent Technologies, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $523.8K | 13 | 43.2% |
| Grant | $441.9K | 4 | 36.4% |
| Long-Term Medical Supply or Device Loan | $171.9K | 3 | 14.2% |
| Honoraria | $69.3K | 20 | 5.7% |
| Travel and Lodging | $6.2K | 15 | 0.5% |
| Food and Beverage | $445.41 | 6 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $931,923.68 (76.8%) of $1,213,515.70 in this company's General Payments records across 23 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Agilent Technologies, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ut Md Anderson Cancer Center
$347,777.43 across 5 reported transactions
- 2
Ucsd Medical Center
$300,000.00 across 1 reported transactions
- 3
University Of Washington Med Ctr
$108,633.27 across 5 reported transactions
- 4
City Of Hope National Medical Ctr
$98,210.87 across 1 reported transactions
- 5
Childrens Hospital Medical Center
$77,302.11 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Agilent Technologies, Inc.'s spend rank (#577 of 1,925, top 30% by spend) and concentration rank (#815 of 1,838, top 44% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Pulse Biosciences, Inc. : $534.8K total payments, HHI 1730
- SS White Burs, Inc. : $65.6K total payments, HHI 1718
- Maquet Cardiovascular L.L.C. : $188.3K total payments, HHI 1714
- GS Solutions, Inc. : $38.7K total payments, HHI 1706
- Mitsubishi Tanabe Pharma Corporation : $92.7K total payments, HHI 1705
- TerSera Therapeutics LLC : $602.9K total payments, HHI 1704
- Agilent Technologies, Inc. (this company) : $1.2M total payments, HHI 1698
- Bolder Surgical, LLC : $49.7K total payments, HHI 1698
- Dompe Farmaceutici S.p.A. : $11.8K total payments, HHI 1694
- Amicus Therapeutics, Inc. : $684.6K total payments, HHI 1692
- Pediatric Alliance LLC : $515.2K total payments, HHI 1687
- Kuros Biosciences AG : $76.3K total payments, HHI 1685
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Agilent Technologies, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Agilent Technologies, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Agilent Technologies, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Anika Therapeutics, Inc.
Perspectum Diagnostics Ltd
Spinal Surgical Strategies, Inc.
Braeburn Inc.
Pulmonx Corporation
Put this to use
Agilent Technologies, Inc. ranks #577 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Agilent Technologies, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Agilent Technologies, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.